265 filings
Page 3 of 14
8-K
4snks6h eeczxcuhn0
16 Mar 23
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
4:24pm
8-K
q39yypqldwo0ihyfhnc
15 Mar 23
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
7:00am
8-K
ggzhoz6jzz2unbzba4ch
13 Mar 23
Regulation FD Disclosure
6:50am
3
o4y9dqqdkz7t tdx5
8 Mar 23
Eton Pharmaceuticals / David Krempa ownership change
2:39pm
4
i4hlvql3ubt4wnf
3 Mar 23
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:10pm
4
3vcl4439
3 Mar 23
Eton Pharmaceuticals / NORBERT G RIEDEL ownership change
4:10pm
4
ia8mamf90lvwa5r4 wp1
3 Mar 23
Eton Pharmaceuticals / PAUL V MAIER ownership change
4:10pm
4
y8ax1
3 Mar 23
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:10pm
4
0kg0lwo1t9g5y7kqyb
3 Mar 23
Eton Pharmaceuticals / James R. Gruber ownership change
4:10pm
4
5d7m4t
3 Mar 23
Eton Pharmaceuticals / Jennifer McKie Adams ownership change
4:10pm
8-K
dou8qh7
1 Mar 23
Departure of Directors or Certain Officers
6:57am
SC 13G/A
ndkyzp3
20 Jan 23
Eton Pharmaceuticals / Opaleye Management ownership change
4:53pm
8-K
0ny9hw5q6gufsuht4fur
11 Jan 23
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
6:50am
8-K
t71sr2
28 Dec 22
Other Events
9:15am
8-K
gisu8a4wxo4peyueun
10 Nov 22
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:15pm
4
5jv cntp47bh
23 Sep 22
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
10:58am
8-K
j2ob rsdz33
13 Sep 22
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
9:15am
8-K
s3n5si
12 Aug 22
Other Events
7:24pm